Key facts
- This page summarizes John Drayton Wise's Form 4 filing for INSMED Inc (INSM).
- 8 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Jan 2025, 18:45.
John Drayton Wise - 07 Jan 2025 Form 4 Insider Report for INSMED Inc (INSM)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- INSM
- Reported as of
- 07 Jan 2025
- Net transaction value
- -$735,374
- SEC form
- 4
- Accepted by SEC
- 10 Jan 2025, 18:45:07 UTC
- Prior SEC filing
- 30 May 2024
- Next SEC filing
- 07 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Drayton Wise, by Michael A. Smith as Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Drayton Wise filed Form 4 for INSMED Inc (INSM) on 10 Jan 2025.
Change
- Previous filing in this sequence was filed on 30 May 2024.
- Current net transaction value: -$735,374.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INSM
transaction
Common Stock
Options Exercise
- Transaction value
- $160,700
- Shares
- +10,000
- Change %
- +8.2%
- Price
- $16.07
- Shares after
- 132,492
- Date
- 07 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
INSM
transaction
Common Stock
Sale
- Transaction value
- $659,800
- Shares
- -10,000
- Change %
- -7.5%
- Price
- $65.98
- Shares after
- 122,492
- Date
- 07 Jan 2025
- Ownership
- Direct
- Footnotes
- F1
INSM
transaction
Common Stock
Sale
- Transaction value
- $191,550
- Shares
- -2,908
- Change %
- -2.4%
- Price
- $65.87
- Shares after
- 119,584
- Date
- 07 Jan 2025
- Ownership
- Direct
- Footnotes
- F3, F4
INSM
transaction
Common Stock
Sale
- Transaction value
- $25,954
- Shares
- -392
- Change %
- -0.33%
- Price
- $66.21
- Shares after
- 119,192
- Date
- 08 Jan 2025
- Ownership
- Direct
- Footnotes
- F3
INSM
transaction
Common Stock
Award
- Transaction value
- Shares
- +6,657
- Change %
- +5.6%
- Price
- Shares after
- 125,849
- Date
- 08 Jan 2025
- Ownership
- Direct
- Footnotes
- F5, F6
INSM
transaction
Common Stock
Sale
- Transaction value
- $18,770
- Shares
- -287
- Change %
- -0.23%
- Price
- $65.40
- Shares after
- 125,562
- Date
- 10 Jan 2025
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INSM
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 07 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $16.07
- Footnotes
- F1, F7
INSM
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +31,930
- Change %
- Price
- $0.000000
- Shares after
- 31,930
- Date
- 08 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,930
- Exercise price
- $65.72
- Footnotes
- F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 8 footnotes
Footnote F1
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Footnote F2
Includes 835 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
Footnote F3
Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units (RSUs) and to cover related broker fees.
Footnote F4
This is the weighted average sales price representing 2,908 shares sold at prices ranging from $65.84 to $65.93 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F5
Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
Footnote F6
Each RSU was granted on January 8, 2025 for no consideration.
Footnote F7
The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
Footnote F8
These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.